Neoadjuvant Immunotherapy: Making Strides.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nd2020-009
Abstract: Neoadjuvant immune checkpoint inhibition is gaining ground as a treatment strategy for early-stage, operable cancers. The list of potentially responsive tumor types now includes Merkel cell carcinoma; recent findings from an arm of the I-SPY2… read more here.
Keywords: immunotherapy making; neoadjuvant immunotherapy; making strides;